What BioNexus Gene Lab Corp does.

BioNexus Gene Lab Corp. is a Wyoming corporation with two principal operating subsidiaries in Malaysia: Chemrex Corporation Sdn. Bhd. (“Chemrex”) and MRNA Scientific Sdn. Bhd. (“MRNA Scientific”). Chemrex is engaged in the distribution of chemical raw materials, primarily for industrial applications in Southeast Asia. MRNA Scientific is engaged in the development and provision of blood-based genomic screening services intended to support early disease risk assessment and health management.

In November 2025, the Company entered into a Share Subscription and Shareholders’ Agreement with Fidelion Diagnostics Pte. Ltd. (“Fidelion”) and related parties, and also entered into an exclusive Southeast Asia intellectual property license arrangement relating to the VitaGuard™ minimal residual disease platform. These transactions expanded the Company’s strategic focus in molecular diagnostics and oncology-related screening technologies.

The Company’s principal executive office is located at Unit A-28-7, Level 28, Tower A, Menara UOA Bangsar, No. 5 Jalan Bangsar Utama 1, 59000 Kuala Lumpur, Malaysia. The Company’s telephone number is +1 307 241 6898 and its website is www.bionexusgenelab.com. Information contained on, or accessible through, the Company’s website is not incorporated by reference into this Annual Report on Form 10-K.

Revenue and profit, by fiscal year.

More on BGLC.

• BioNexus Gene Lab Corp summary
• BioNexus Gene Lab Corp financial statements
• BioNexus Gene Lab Corp key metrics
• BioNexus Gene Lab Corp health scores and style box
• BioNexus Gene Lab Corp earnings
• BioNexus Gene Lab Corp dividends
• BioNexus Gene Lab Corp valuation
• BioNexus Gene Lab Corp ownership and insiders
• BioNexus Gene Lab Corp peers

Figures from BioNexus Gene Lab Corp's filings with the U.S. SEC, standardised automatically; prices are end-of-day closes. Not financial advice.